Clinical trial
A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied…
NCT00417937 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00417937 |
|---|---|
| Title | A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily |
| Official title | A Multicenter, Double-Blind Clinical Trial to Assess the Efficacy and Tolerability of Topical Azelaic Acid 15% Gel Once Daily Compared to Topical Azelaic Acid 15% gelTwice Daily in Subjects With Papulopustular Rosacea |
| Lead sponsor | LEO Pharma, Industry |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Papulopustular Rosacea |
| Intervention type | Drug |
| Interventions | azelaic acid 15% gel |
| Enrollment | 98 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jan 4, 2007 |
| Last update posted | Jun 9, 2023 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: